Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy K Keating

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Blood|August 1, 2009
Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemiaRachel M A Linger, Deborah DeRyckere, Luis Brandão, et al.
Blood Advances|June 28, 2019
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemiaAmy K Keating, Nathan Gossai, Christine L Phillips, et al.
Journal of Leukocyte Biology|April 24, 2009
Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stressAdil Anwar, Amy K Keating, David Joung, et al.
Blood Advances|February 6, 2019
Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patientsJenna Sopfe, Laura Pyle, Amy K Keating, et al.
Molecular Genetics and Metabolism|May 24, 2011
Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuriaAmy K Keating, Cynthia Freehauf, Hua Jiang, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivityAmy K Keating, Grace K Kim, Ashley E Jones, et al.
Plos One|October 27, 2016
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma MultiformeAlexandra Sufit, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemiaDouglas K Graham, Dana B Salzberg, Joanne Kurtzberg, et al.
Blood|July 18, 2013
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemiaRachel M A Linger, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
Blood Advances|April 7, 2019
The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemiaAmy K Keating, Jurgen Langenhorst, John E Wagner, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Blood|August 1, 2009
Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemiaRachel M A Linger, Deborah DeRyckere, Luis Brandão, et al.
Blood Advances|June 28, 2019
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemiaAmy K Keating, Nathan Gossai, Christine L Phillips, et al.
Journal of Leukocyte Biology|April 24, 2009
Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stressAdil Anwar, Amy K Keating, David Joung, et al.
Blood Advances|February 6, 2019
Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patientsJenna Sopfe, Laura Pyle, Amy K Keating, et al.
Molecular Genetics and Metabolism|May 24, 2011
Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuriaAmy K Keating, Cynthia Freehauf, Hua Jiang, et al.
Molecular Cancer Therapeutics|April 29, 2010
Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivityAmy K Keating, Grace K Kim, Ashley E Jones, et al.
Plos One|October 27, 2016
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma MultiformeAlexandra Sufit, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemiaDouglas K Graham, Dana B Salzberg, Joanne Kurtzberg, et al.
Blood|July 18, 2013
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemiaRachel M A Linger, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
Blood Advances|April 7, 2019
The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemiaAmy K Keating, Jurgen Langenhorst, John E Wagner, et al.
Pageof 6